BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹13 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of BAL PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹17 Cr |
Mar2023 | ₹16 Cr |
Mar2022 | ₹16 Cr |
Mar2021 | ₹13 Cr |
Mar2020 | ₹13 Cr |
How is Contingent Liabilities of BAL PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹17 Cr | 3.16 | |
Mar2023 | ₹16 Cr | 1.18 | |
Mar2022 | ₹16 Cr | 25.01 | |
Mar2021 | ₹13 Cr | 0.00 | |
Mar2020 | ₹13 Cr | - |
Compare Contingent Liabilities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹182.5 Cr | 0.4% | -6.1% | -12.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 0.4% |
-6.1% |
-12.3% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses